JP2013545440A - マカカ・ファシキュラリス（Ｍａｃａｃａｆａｓｃｉｃｕｌａｒｉｓ）ＣＣＬ１７ - Google Patents

マカカ・ファシキュラリス（Ｍａｃａｃａｆａｓｃｉｃｕｌａｒｉｓ）ＣＣＬ１７ Download PDF

Info

Publication number
JP2013545440A
JP2013545440A JP2013530394A JP2013530394A JP2013545440A JP 2013545440 A JP2013545440 A JP 2013545440A JP 2013530394 A JP2013530394 A JP 2013530394A JP 2013530394 A JP2013530394 A JP 2013530394A JP 2013545440 A JP2013545440 A JP 2013545440A
Authority
JP
Japan
Prior art keywords
ccl17
polypeptide
seq
modulator
macaca
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013530394A
Other languages
English (en)
Japanese (ja)
Inventor
ナソ，マイケル
ライアン，メアリー
サンチュリ−マロット，サンドラ
スウェンキ−アンダーウッド，ベサニー
Original Assignee
ヤンセン バイオテツク，インコーポレーテツド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ヤンセン バイオテツク，インコーポレーテツド filed Critical ヤンセン バイオテツク，インコーポレーテツド
Publication of JP2013545440A publication Critical patent/JP2013545440A/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/866—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving immunoglobulin or antibody fragment, e.g. fab', fab, fv, fc, heavy chain or light chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP2013530394A 2010-09-27 2011-09-26 マカカ・ファシキュラリス（Ｍａｃａｃａｆａｓｃｉｃｕｌａｒｉｓ）ＣＣＬ１７ Pending JP2013545440A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US38669510P 2010-09-27 2010-09-27
US61/386,695 2010-09-27
US39128810P 2010-10-08 2010-10-08
US61/391,288 2010-10-08
PCT/US2011/053255 WO2012047584A2 (en) 2010-09-27 2011-09-26 Macaca fascicularis ccl17

Publications (1)

Publication Number Publication Date
JP2013545440A true JP2013545440A (ja) 2013-12-26

Family

ID=45890006

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013530394A Pending JP2013545440A (ja) 2010-09-27 2011-09-26 マカカ・ファシキュラリス（Ｍａｃａｃａｆａｓｃｉｃｕｌａｒｉｓ）ＣＣＬ１７

Country Status (7)

Country Link
US (1) US9012602B2 (zh)
EP (1) EP2625523A4 (zh)
JP (1) JP2013545440A (zh)
CN (1) CN103124904B (zh)
CA (1) CA2812392A1 (zh)
IL (1) IL225396A (zh)
WO (1) WO2012047584A2 (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016537024A (ja) * 2013-11-06 2016-12-01 ヤンセン バイオテツク，インコーポレーテツド 抗ｃｃｌ１７抗体

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115820741A (zh) * 2022-03-11 2023-03-21 郑州大学第一附属医院 表达载体、淋巴瘤细胞、小鼠淋巴瘤模型及其构建方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003510078A (ja) * 1999-09-28 2003-03-18 ジェンテスト・コーポレーション Ｍａｃａｃａｆａｓｃｉｃｕｌａｒｉｓ由来のＰ−糖タンパク質およびその使用
JP2008502905A (ja) * 2004-06-15 2008-01-31 セントカー・インコーポレーテツド ヒト前立腺疾患に対する作用物質のスクリーニング法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2543631A1 (en) 2003-11-07 2005-05-26 Amgen Inc. Monkey immunoglobulin sequences
CA2602946A1 (en) * 2005-03-22 2006-09-28 Medstar Health, Inc. Delivery systems and methods for diagnosing and treating cardiovascular diseases
US7585968B2 (en) * 2005-03-28 2009-09-08 Isis Pharmaceuticals, Inc. Compositions and their uses directed to thymus and activation-regulated chemokine (TARC)
US20070072175A1 (en) 2005-05-13 2007-03-29 Biogen Idec Ma Inc. Nucleotide array containing polynucleotide probes complementary to, or fragments of, cynomolgus monkey genes and the use thereof
WO2009086514A1 (en) * 2007-12-28 2009-07-09 Dana-Farber Cancer Institute, Inc. Humanized monoclonal antibodies and methods of use
US7931905B2 (en) * 2008-05-22 2011-04-26 Centocor Ortho Biotech Inc. Cynomolgus gp80 receptor and uses thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003510078A (ja) * 1999-09-28 2003-03-18 ジェンテスト・コーポレーション Ｍａｃａｃａｆａｓｃｉｃｕｌａｒｉｓ由来のＰ−糖タンパク質およびその使用
JP2008502905A (ja) * 2004-06-15 2008-01-31 セントカー・インコーポレーテツド ヒト前立腺疾患に対する作用物質のスクリーニング法

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
JPN6015030132; Ａｃｃｅｓｓｉｏｎ　Ｎｏ．　ＮＭ＿００１０３２８５２ *
JPN6015030134; Ｊ．　Ｃｌｉｎ．　Ｍｉｃｒｏｂｉｏｌ． Ｖｏｌ．２８，　Ｎｏ．１０, 1990, ｐｐ．２２８５-２２９０ *
JPN6015030136; Ｊ．　Ｓｔｅｒｏｉｄ　Ｂｉｏｃｈｅｍ．　Ｍｏｌ．　Ｂｉｏｌ． Ｖｏｌ．８５, 2003, ｐｐ．２３５-２４５ *
JPN6015030139; Ｊ．　Ｉｍｍｕｎｏｌ． Ｖｏｌ．１６０, 1998, ｐｐ．４０３-４０９ *
JPN6015030141; Ｊ．　Ｉｍｍｕｎｏｌ． Ｖｏｌ．１６６, 2001, ｐｐ．２０５５-２０６２ *
JPN6015030142; Ｊ．　Ｉｍｍｕｎｏｌ． Ｖｏｌ．１７３, 2004, ｐｐ．４６９２-４６９８ *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016537024A (ja) * 2013-11-06 2016-12-01 ヤンセン バイオテツク，インコーポレーテツド 抗ｃｃｌ１７抗体

Also Published As

Publication number Publication date
EP2625523A4 (en) 2014-03-12
CA2812392A1 (en) 2012-04-12
WO2012047584A3 (en) 2012-06-21
US9012602B2 (en) 2015-04-21
IL225396A0 (en) 2013-06-27
EP2625523A2 (en) 2013-08-14
CN103124904A (zh) 2013-05-29
WO2012047584A2 (en) 2012-04-12
US20120082622A1 (en) 2012-04-05
IL225396A (en) 2016-04-21
CN103124904B (zh) 2015-06-03

Similar Documents

Publication Publication Date Title
US8383788B2 (en) C-Fos induced growth factor (FIGF) and DNA encoding same
ES2625316T3 (es) Neuquinasa, una proteína corriente abajo de neuregulina
JP7225116B2 (ja) Ｌａｇ－３に対する結合親和性を有するリポカリンムテイン
JP2007530055A (ja) Ｂｍｐ−３プロペプチドおよび関連する方法
US7575751B2 (en) Activin-A mutants
US20070111944A1 (en) Purification of vascular endothelial growth factor-B
AU2015369808A1 (en) Methods of improving yield in recombinant protein production
CN110234760B (zh) 用于治疗年龄相关性黄斑变性的肽
CN114846024A (zh) Il-37融合蛋白及其用途
JP2013545440A (ja) マカカ・ファシキュラリス（Ｍａｃａｃａｆａｓｃｉｃｕｌａｒｉｓ）ＣＣＬ１７
JPH03164183A (ja) 脳由来の膜蛋白質発現系
JP2005503139A (ja) 炎症性及び線維症性疾患治療用の精製組み換えヒトウテログロビンの製造方法
US7897358B2 (en) Canine transient receptor potential V2 (cTRPV2) and methods of screening for TRPV2 channel modulators
US20040137588A1 (en) Purification of vascular endothelial growth factor-b
US7879978B2 (en) Macaca fascicularis ST2L
SG193483A1 (en) Variants of human gdnf
CA2710760C (en) Cynomolgus toll-like receptor 3
Shastry et al. Overproduction and partial purification of the Norrie disease gene product, norrin, from a recombinant baculovirus
WO2023108666A1 (zh) 一类靶向covid-19病毒s蛋白的超高亲和力小蛋白及用途
KR20190025569A (ko) Tgf-베타 슈퍼패밀리의 ab6 패밀리 디자이너 리간드
EP2356216B1 (en) Papio cynocephalus toll-like receptor 3
WO2023212629A2 (en) De novo designed binders targeting human epcam and pdl1 receptors
RU2024103715A (ru) Рекомбинантные варианты белков r-спондинов и их применение
KR20190005239A (ko) Tgf-베타 슈퍼패밀리의 ab6 패밀리 디자이너 리간드를 포함하는 간질환 치료용 조성물 및 그의 이용
US20060116338A1 (en) Mammalian early developmental regulator gene

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20140814

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150728

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20160105